Cerus Corporation announces Vivek Jayaraman as its next President and CEO

Cerus Corporation elevates COO Vivek Jayaraman to President and CEO to spearhead the next era of global commercial growth and blood safety innovation.

On March 16, Cerus Corporation announced the promotion of Vivek Jayaraman, its current COO, to president and CEO, effective July 1. With this appointment, he will also join the Board of Directors. Incumbent CEO William Obi Greenman will transition to executive chairman after over 15 years leading the company. Jayaraman's promotion follows his roles as chief commercial officer since 2016 and COO since 2020. Previously, he led commercial expansion at TriVascular, held an executive position at Medtronic, and earned an MBA from the Wharton School at the University of Pennsylvania.

Cerus Corporation is a California-based biotechnology company that develops and provides blood safety treatment systems that reduce pathogens in human blood. The INTERCEPT Blood system platform has been the key driver of growth. Its products are used throughout the healthcare industry, including by hospitals and blood centers worldwide. Moreover, Jayaraman was responsible for driving strategies that increased annual revenue by nearly 5 times from under $40 million to more than $200 million in 2025. The upward trend continued in the last twelve months with revenues reaching $206 million. This positive showing also increased investor confidence in terms of the company’s targeted expansion strategies in blood safety technologies. Recognizing this, analysts forecast a 21% growth in 2026.

Furthermore, commenting on the development. Jayaraman said, “I’m honored to lead Cerus during this next chapter”. Among his priorities are strengthening the company’s position in transfusion medicine and expanding global access to the company’s INTERCEPT Blood System. At CIO Bulletin, we view this transition strategy being aligned with present CEO Greenman’s tenure as the CEO since 2011. Jayaraman is well poised to capitalize on Greenman’s achievement of overseeing the company’s transition from a nascent business into a global commercial enterprise with sales in more than 40 countries.